Showing results (61-70 of 123) with videos related to
Sort By:
Pageof 13
The American Journal of Gastroenterology|May 16, 2000
A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitisR D Cohen, D M Woseth, R A Thisted, et al.Gastroenterology|December 1, 1986
Prevalence and incidence of inflammatory bowel disease in family membersB A Lashner, A A Evans, J B Kirsner, et al.The American Journal of Gastroenterology|September 1, 1993
Long-term management of Crohn's disease with mesalamine capsules (Pentasa). Pentasa Crohn's Disease Compassionate Use Study GroupS B Hanauer, E L Krawitt, M Robinson, et al.Alimentary Pharmacology & Therapeutics|January 25, 2011
Randomised clinical trial: delayed-release oral mesalazine 4.8 g/day vs. 2.4 g/day in endoscopic mucosal healing--ASCEND I and II combined analysisG R Lichtenstein, D Ramsey, D T RubinClinical Therapeutics|November 26, 1998
Advances in the management of Crohn's disease: economic and clinical potential of infliximabS B Hanauer, R D Cohen, R V Becker, et al.Alimentary Pharmacology & Therapeutics|May 25, 2010
Clinical trial: impact of prior infliximab therapy on the clinical response to certolizumab pegol maintenance therapy for Crohn's diseaseS B Hanauer, J Panes, J-F Colombel, et al.Gastroenterology|August 1, 1989
Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case-control studyB A Lashner, P A Heidenreich, G L Su, et al.Cancer|November 1, 1981
Disseminated Trichosporon beigelii (cutaneum)C W Yung, S B Hanauer, D Fretzin, et al.Hepatology (Baltimore, Md.)|January 1, 1985
Pattern and prognosis of liver function test abnormalities during parenteral nutrition in inflammatory bowel diseaseJ M Bengoa, S B Hanauer, M D Sitrin, et al.Gastroenterology|December 2, 1999
Thalidomide therapy for patients with refractory Crohn's disease: an open-label trialE D Ehrenpreis, S V Kane, L B Cohen, et al.Pageof 13